137 related articles for article (PubMed ID: 7223316)
1. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects.
Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE
Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316
[TBL] [Abstract][Full Text] [Related]
2. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man.
Delitala G; Devilla L; Lotti G
J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791
[TBL] [Abstract][Full Text] [Related]
3. On the role of dopamine receptors in the central regulation of human TSH.
Delitala G; Devilla L; Canessa A; D'Asta F
Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
[TBL] [Abstract][Full Text] [Related]
4. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
5. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
[TBL] [Abstract][Full Text] [Related]
7. Domperidone: a novel agent for the investigation of anterior pituitary function and control in man.
Pourmand M; Rodriguez-Arnao MD; Weightman DR; Hall R; Cook DB; Lewis M; Scanlon MF
Clin Endocrinol (Oxf); 1980 Feb; 12(2):211-5. PubMed ID: 7398098
[TBL] [Abstract][Full Text] [Related]
8. Pituitary hormone secretion after inhibition of L-aromatic amino acid decarboxylase activity in man.
Delitala G; Devilla L; Pende A
Acta Endocrinol (Copenh); 1980 Dec; 95(4):438-43. PubMed ID: 7456974
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.
Camanni F; Genazzani AR; Massara F; La Rosa R; Cocchi D; Müller EE
Neuroendocrinology; 1980; 30(1):2-6. PubMed ID: 7354887
[TBL] [Abstract][Full Text] [Related]
12. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion.
Kaufman JM; Elewaut A; Vermeulen A
Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092
[TBL] [Abstract][Full Text] [Related]
13. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
Sowers JR; Sharp B; McCallum RW
J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
[TBL] [Abstract][Full Text] [Related]
14. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
15. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
[TBL] [Abstract][Full Text] [Related]
16. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
Frey HM; Haug E
Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
[TBL] [Abstract][Full Text] [Related]
17. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma prolactin levels in ovariectomized thyroidectomized rats treated with estrogen.
Pan JT; Chen CW
Endocrinology; 1990 Jun; 126(6):3146-52. PubMed ID: 1972060
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
Ghigo E; Pogliano G; Campagnoli C; Bertagna A; Camanni F; Massara F
J Endocrinol Invest; 1984 Oct; 7(5):525-7. PubMed ID: 6439773
[TBL] [Abstract][Full Text] [Related]
20. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
